| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Rush Medical College at Rush-Presbyterian-St. Lukes Medical Center, Chicago, Illinois
Address correspondence to Jeffrey S. Kroin, PhD, Department of Anesthesiology, Rush Medical College, 1653 W. Congress Parkway, Chicago, IL 60612. Address e-mail to jkroin{at}rush.edu
| Abstract |
|---|
|
|
|---|
IMPLICATIONS: A rat model was developed to evaluate different drugs that may be injected epidurally to treat postdural puncture headache. Epidural injection of blood or fibrin glue was the most effective method of maintaining increased cerebrospinal fluid pressure after dural puncture. Sealing the dural defect does not effectively correct cerebrospinal fluid pressure unless an epidural tamponade effect is maintained.
| Introduction |
|---|
|
|
|---|
The mechanism(s) by which a dural puncture leads to headache symptoms is controversial (14). It is generally believed that headache results from the loss of cerebrospinal fluid (CSF), causing a downward shift of the brain and stimulating pain-sensitive nerve fibers. In addition, the loss of CSF volume may produce a compensatory cerebral vasodilation that has been classically associated with other types of headaches. Biochemical mechanisms, such as stimulation of adenosine receptors, may also be involved (5).
The epidural blood patch (EBP) is often considered the "gold standard" for treatment of PDPH, and is used when there is not prompt spontaneous resolution or when there is failure of pharmacologic management, such as caffeine. Two mechanisms have been proposed for the effectiveness of the EBP (69). One hypothesis is that the transmitted pressure from the epidural injection (a tamponade effect) causes an increase in intracranial pressure (ICP) that restores the brain to its normal position. The other possibility is that epidurally injected blood seals the dural defect and normal CSF production eventually replenishes the lost CSF and restores brain homeostasis. However, the two mechanisms may be complementary with the almost immediate relief of headache symptoms after EBP readily explained by the first mechanism (because human CSF production is only 0.35 mL/min), whereas the continued maintenance of headache relief, even after the epidural blood mass has resolved within a few hours (6), is consistent with the second mechanism.
Although an EBP using autologous blood is relatively easy to perform, there may be circumstances (such as systemic or localized sepsis) when this should be avoided. For this reason, the injection or infusion of nonblood substitutes (1012) or commercially available fibrin glue (13,14) have been evaluated as replacement for the traditional autologous EBP. Although there are reports of successful outcomes with these alternatives, there are limited data from controlled trials detailing relative efficacy of alternative epidural injectates after dural puncture, and comparisons of case studies are hindered by inhomogeneity of patient characteristics and epidural injection methods for PDPH.
Considering the likely mechanism(s) by which EBP is effective after dural puncture, we designed an animal model to systemically evaluate the change in CSF pressure in response to different types of epidural administration of blood, blood products, colloids, and crystalloids via bolus injections or continuous infusions. The primary goal of this study was to compare the relative efficacy of these methods for achieving sustained correction of intracranial hypotension after dural puncture in a controlled model. A secondary goal was to gain insight into the mechanism(s) by which EBP modulates CSF pressure.
| Methods |
|---|
|
|
|---|
|
Bolus Injection Studies
An epidural injection of saline (0.9% sodium chloride injection) 100 µL was made over 60 s by using a 1000-µL microsyringe. The CM pressure was then monitored over the next 30 min, during which time the initial pressure increase had subsided and returned to postdural puncture baseline level (see Results). Any animal in which the CM pressure did not increase at least 2 mm Hg initially after saline injection was excluded from the study, under the assumption that there was a leak around the epidural catheter. After saline injection, another 100-µL epidural injection was performed over 60 s, with 6 groups (n = 5/group): whole blood (obtained from cardiac puncture of a donor rat), donor whole blood injected 2 cm above the lumbar dural puncture, donor whole blood anticoagulated with potassium EDTA, 6% hetastarch in saline (Baxter, Deerfield, IL), 10% dextran 40 in saline (McGaw, Irvine, CA), or 32% dextran 70 in dextrose (Hyskon; Cooper, Shelton, CT). In a slight modification of the above experiment, another group of animals (n = 5) had two separate epidural catheters placed 5 mm into the epidural space to allow simultaneous injections of 50 µL each of a two-component commercially available fibrin glue (Tisseel VH kit; Baxter, Glendale, CA), after the saline injection. In each of the above groups, CM pressure was monitored for 240 min after epidural injection. The observers could not be blinded to the type of epidural injectates, because the physical properties (color, density, etc.) of each of the solutions differed greatly.
To evaluate the time course of CM pressure changes after lumbar dural puncture without intervention, a group (n = 5) was included in which no injections were performed after dural puncture. In two other groups (n = 5/group), a laminectomy was performed at the L4-5 vertebrae, a lumbar dural puncture performed, and 30 min later, the dura-arachnoid defect sealed by direct application of either 100-µL Vetbond adhesive or whole donor blood. This was to investigate the effect of sealing the CSF leak on CM pressure, without the tamponade effect of the fluid bolus in the closed epidural space. An additional group (n = 5) received a subcutaneous injection of 3 mg of caffeine sodium benzoate after dural puncture.
The criterion for evaluating efficacy was the duration of time (up to 240-min measurement interval) that CM pressure was >1 mm Hg above preinjection postdural puncture pressure. This definition was chosen because small physiologic drifts in CSF pressure >4 h could cause a slight increase in CM pressure that could be misleadingly interpreted as a maintenance of increased pressure unless some threshold value is chosen. In all of the above experiments, there were five animals in each group, with the results recorded as the mean ± SE. CM pressures before and after lumbar dural puncture, and peak CM pressures after bolus injections were compared using analysis of variance for repeated measures and Bonferroni corrected paired t-tests. The durations of CM pressure increase were compared among groups using a one-way analysis of variance and the Tukey-B multiple-comparison method.
Continuous Infusion Studies
Animals were prepared as described above. All animals then received a 100-µL epidural bolus of either saline or 10% dextran 40 over 60 s followed by a continuous infusion of 60, 120, 180, or 300 µL/h of the same solution. CM pressure was monitored for 180 min, infusion terminated, and pressure monitored an additional 60 min. There were 47 animals in each of the 8 infusion groups. The percent of animals with increased CM pressure at 180 and 240 min from the start of injection was compared by using the Fishers exact test.
| Results |
|---|
|
|
|---|
|
|
|
Continuous Infusion Studies
CM pressure declined by 3.8 ± 0.8 mm Hg after dural puncture in animals assigned to receive continuous epidural infusions. The initial increase of CM pressure after the 100-µL epidural injection of saline or 10% dextran 40 was not different than the animals in the bolus injection studies. The maintenance of CM pressure elevation at different flow rates is shown in Figure 5. After 180 min, a 300 µL/h saline infusion maintained pressure above postdural puncture baseline in the majority of animals. However, once the epidural infusion was discontinued, the pressure was at baseline within 60 min in all animals in all infusion groups (Fig. 5).
|
| Discussion |
|---|
|
|
|---|
In 1967, Usubiaga et al. (19) injected 20 mL of saline epidurally in patients with PDPH and measured the pressure in the lumbar subarachnoid space. There was a large increase in pressure initially, but it returned to baseline within 310 minutes. After the initial report of the successful treatment of PDPH by Gormley (20) with EBP, Coombs and Hooper (18) injected 15 mL of autologous blood epidurally and measured lumbar subarachnoid pressure. Initially, the pressure increased to 6.8 mm Hg, from a postdural puncture baseline of 1.7 mm Hg, but instead of declining rapidly, it was still at 4.8 mm Hg at 15 minutes postinjection. We intentionally modeled our experiments after that study. The 100-µL epidural injection volume we chose in the rat corresponds approximately to a 15-mL volume in a human, because based on body weight (e.g., 60 kg human/0.4 kg rat) or CSF turnover rate, the scaling factor from rat to human is about 150. Our experiments in the rat showed an initial increase in CM pressure of 7.2 mm Hg after epidural bolus injection, which is slightly higher than the 5.1 mm Hg increase in lumbar subarachnoid CSF pressure in patients.
Our experience with bolus epidural saline injections in the rat, showing a return to baseline pressure in 7.8 minutes, is similar to the duration measured in patients (19). Single epidural injections of 2 commonly used blood substitutes, 6% hetastarch and 10% dextran 40 proved to be no better than equal volumes of saline in restoring CM pressure. It should be cautioned, however, that with n = 5/group, there may actually be a difference between these blood substitutes and saline, but our statistical tests do not have sufficient power to detect it. One clinical report indicates that epidural dextran 40 injection provides relief from PDPH (10). Because additional clinical reports used a protocol of a bolus injection of dextran 40 followed by a maintenance infusion at 15% of the initial volume/hour (1112), we evaluated that strategy in our rat model. As Figure 5 shows, there was little success in increasing CM pressure even with a maintenance dextran 40 infusion of 120% initial volume/hour. It is noteworthy that at very fast rates of infusion (300% initial volume/hour), a sizeable proportion of animals had increased CM pressure at 180 minutes (only significant for the saline group). However, when epidural infusion was terminated, the CM pressure returned to postdural puncture baseline within an hour, indicating that in this model, no permanent recovery was achieved by maintenance infusion of 10% dextran 40 or saline.
Our rat model provides insight into the mechanisms involved in the correction of intracranial hypotension by the EBP technique. When the epidural injection site was between the lumbar dural puncture (20 mm above the puncture) and the CM monitoring site, rather than contiguous with the puncture site, the same initial increase in CM pressure followed the 100-µL injection of blood or saline. However, that method of epidural blood injection maintained increased CM pressure for a significantly shorter interval (27.0 minutes) than blood injected in continuity with the dural puncture. Therefore, it seems to be essential that the EBP be delivered close to the dura-arachnoid defect. Presumably, the increased "mass effect" of blood compressing the CSF space cannot solely compensate for the continued leakage of CSF at the lumbar site. The addition of EDTA to whole blood also resulted in a significant reduction of the duration of CM pressure increase. Although the mean time to return to postdural puncture baseline (33.4 minutes) was longer than with epidural saline, the overall results were inferior compared with unmodified whole blood. Therefore, the coagulability of blood also seems to be essential for producing the long-term effect of maintaining CM pressure correction. Finally, opening the epidural space with a laminectomy, and applying whole blood or tissue adhesive caused no increase in CM pressure, confirming the importance of the tamponade effect (6,7).
Our results in this rat model comport with the widely held opinion that EBP is the "gold standard" for treating PDPH. The injection of 100 µL of fresh whole blood consistently maintained an increased CM pressure over the 240-minute measurement period. This is consistent with magnetic resonance imaging studies showing that the mass effect from EBP in humans lasts 37 hours (6). It would have been desirable to follow the CM pressure for a longer time interval to demonstrate a permanent sealing effect in the dura-arachnoid of the whole blood injection, and maintenance of CM pressure related to CSF production. However, attempts to extend the total experiment time were not fruitful because after 6 hours of halothane anesthesia, we began to observe a decreased heart rate and a change in the pattern of the CM pressure from a typical pulse pattern to an atypical sinusoidal waveform.
The use of fibrin glue was a successful method of producing a sustained increase of CM pressure, and may be a viable alternative to an autologous blood patch if there is systemic sepsis. Fibrin glue seals lumbar CSF leakage in patients with intrathecal catheters (13), and in pigs after dural puncture (14). Our 100-µL injection in a rat corresponds to a 15-mL epidural injection in a human, so the relative amount of fibrin glue evaluated in the study is larger than has been used in humans for a comparable purpose (13). Nonetheless, the fibrin glue injection in our rat model demonstrates that a substance with both mass effect and sealing ability can maintain increased CM pressure.
Methods involving mechanisms other than restoring ICP to normal can be effective for treating PDPH. An example of this is the systemic injection of caffeine, which produced an immediate negative effect in our model by even further reducing CM pressure after dural puncture. The latter observation suggests that this common pharmacologic treatment is effective for PDPH because of its cerebral vasoconstrictive properties (5,21), without increasing CSF pressure. Another important consideration when evaluating the effects of interventions used for PDPH is the anatomical differences between species. The much thicker human dura-arachnoid membrane compared with the rat may have better self-sealing properties in response to external pressure or it may be more easily plugged by colloids such as dextran 40. This may explain why saline (19) or dextran 40 (1012) epidural application has been used successfully in patients, but seems to be ineffective in the rat model. One aspect of PDPH not addressed in our acute experiments is the time delay between a dural puncture and the appearance of headache symptoms that can occur days after the precipitating event (1,4). In the rat model, the decrease in CM pressure is almost immediate and the epidural injections were performed soon afterward. These differences mandate caution in translating the results of this controlled animal model to the clinical spectrum of PDPH. Despite certain limitations, our rat model seems to be a useful method for evaluating mechanisms and quantifying relative efficacy of approaches designed to restore ICP after dural puncture.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Ishikawa, M. Yokoyama, S. Mizobuchi, H. Hashimoto, E. Moriyama, and K. Morita Epidural Blood Patch Therapy for Chronic Whiplash-Associated Disorder Anesth. Analg., September 1, 2007; 105(3): 809 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Monsel, G. Rodesch, P.-A. Laloe, G. Kuhlman, and M. Fischler Neurologic Dysfunction After Major Thoracic Surgery in a Patient with Severe Arteriosclerotic Disease Receiving Epidural Analgesia Anesth. Analg., January 1, 2007; 104(1): 204 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rosser, J. Finkel, G. Vezina, and M. Majd Postural Headache in a Child With Marfan Syndrome: Case Report and Review of the Literature J Child Neurol, February 1, 2005; 20(2): 153 - 155. [Abstract] [PDF] |
||||
![]() |
M. J. Cousins, D. Brazier, and R. Cook Intracranial Hypotension Caused by Cervical Cerebrospinal Fluid Leak: Treatment with Epidural Blood Patch Anesth. Analg., June 1, 2004; 98(6): 1794 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aldrete, J. Barrios-Alarcon, S. Sagadai, A. Hunningher, R. Bell, and D. K. Turnbull Post-dural puncture headache: pathogenesis, prevention and treatment Br. J. Anaesth., May 1, 2004; 92(5): 767 - 770. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|